tiprankstipranks
Trending News
More News >
Eagle Pharmaceuticals Inc (EGRX)
OTHER OTC:EGRX
US Market

Eagle Pharmaceuticals (EGRX) Cash flow

Compare
212 Followers

Eagle Pharmaceuticals Cash Flow

EGRX's free cash flow for Q2 2023 was $-132.00K. For the 2023 fiscal year, EGRX's free cash flow was decreased by $22.63M and operating cash flow was $-126.00K. See a summary of the company’s cash flow.
Cash Flow
Dec 22Dec 21Dec 20Dec 19Dec 18
Operating Cash Flow
$ 50.70M$ 28.22M$ 49.50M$ 55.99M$ 52.38M
Investing Cash Flow
$ -86.83M$ -5.32M$ -18.25M$ -777.00K$ -133.00K
Financing Cash Flow
$ -6.21M$ -28.39M$ -37.87M$ -24.23M$ -88.12M
End Cash Position
$ 55.32M$ 97.66M$ 103.16M$ 109.78M$ 78.79M
Free Cash Flow
$ 50.52M$ 27.90M$ 48.75M$ 55.21M$ 52.25M
Currency in USD

Eagle Pharmaceuticals Cash Flow